Revenue - Revenue Recognition (Details) - Revenue Benchmark	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100.00%	100.00%
Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100.00%	100.00%
Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100.00%	100.00%
Americas | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	44.00%	45.00%
Europe, Middle East, Africa | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	47.00%	45.00%
Asia Pacific | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	9.00%	10.00%
High-Value Product Components | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	51.00%	56.00%
High-Value Product Delivery Devices | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	7.00%	5.00%
Standard Packaging | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	23.00%	23.00%
Contract-Manufactured Products | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	19.00%	16.00%
Biologics | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	34.00%	43.00%
Generics | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	20.00%	17.00%
Pharma | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	27.00%	24.00%
Contract-Manufactured Products | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	19.00%	16.00%